OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

Department for International Development, UK, to boost Kenya’s business development.

Posted .

The UK’s Department for International Development (DFID) will spend £19 million (Sh2.7billion) in wealth creation projects in Kenya in 2015. Kenya is one of GAFFI’s ‘demonstration’ countries with improved diagnostic facilities planned for all the major hospitals.   The planned investment is aimed at helping the Kenyan economy achieve a 10 per cent growth rate… Read more »

Read more >

GAFFI recognises world AIDS day, by applying for Itraconazole to be included on Essential Medicines List

Posted .

Pioneering health charity GAFFI  is today calling on the World Health Organisation (WHO) to help hundreds of thousand of AIDS and HIV positive patients worldwide by including itraconazole on the Essential Medicine List (EML). GAFFI’s application to  the WHO, in collaboration with the International Foundation for Dermatology, pinpoints key fungal diseases in AIDS for which… Read more »

Read more >

Boost for lung infection research – with new UK-Brazil partnership

Posted .

 A Brazilian University is forming a new international partnership with researchers from Manchester to carry out more research into the  fungal lung infection which causes chronic illness in  at least three million people worldwide and has a fatality of 75%. Colleagues at the Escola Paulista de Medicina-Federal University of Sao Paulo (UNIFESP) will work alongside… Read more »

Read more >

Burden of fungal infection in Argentina, Australia, Belgium, Mexico, Saudi Arabia & Tanzania presented at ICAAC

Posted .

At the ICAAC 2014 conference being held in Washington DC, data for a further 6 country “burdens of serious fungal disease”  has been estimated, for 260 million people. The rate of candidaemia in Saudi Arabia is amongst the highest in the world at 10/100,000 which contrasts with low rates in Argentina (1.1/100,000) and Australia (1.87/100,000)…. Read more »

Read more >

Follow up lumbar puncture, days after diagnosis, reduces death from cryptococcal meningitis in AIDS

Posted .

High opening pressure at lumbar puncture (LP) (spinal tap) is recognised as a poor prognostic feature of cryptococcal meningitis. For these patients repeated LP is advocated, including the use of lumbar drains or ventricular shunts in some cases. In a provocative paper from Uganda, Rolfes and colleagues found that at least one ‘therapeutic’ LP for… Read more »

Read more >

GAFFI President delivers keynote speech in Montreal on global burden of human fungal diseases

Posted .

To a packed audience of researchers and science policy makers, GAFFI President Dr David Denning described the enormous and under-appreciated burden of fungal infections at the International Union of Microbiological Societies meeting in Montreal. Very large numbers of people are affected, and many fungal disease estimates have yet to be made, so estimates are incomplete…. Read more »

Read more >

New device to detect invasive aspergillosis

Posted .

A new lateral flow device has been invented by Prof Chris Thornton of Exeter University, UK, to accurately diagnose invasive pulmonary aspergillosis. The affordable device uses a highly specific monoclonal antibody which detects a diagnostic marker of Aspergillus infection and uses a small blood sample. Aspergillosis is a notoriously difficult disease to diagnose -affecting many… Read more »

Read more >